Janux Therapeutics, Inc.
JANXNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for JANX. That does not mean none is planned.
Get an email about JANX's next catalysts
Track Janux Therapeutics (JANX) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 0 past
JANX Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-0.45 | FQ end Sep/2026 | Call: tbd
Market Overview
Stock performance and key metrics
No drugs found in this phase.
Frequently asked questions
When is Janux Therapeutics, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Janux Therapeutics, Inc. (JANX) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track JANX biotech catalysts?→
Add JANX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Janux Therapeutics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.